Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Duloxetine 60 mg in Healthy Adults (Fed)
NCT02291341Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- May 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of duloxetine in major depressive disorder (MDD), generalized anxiety disorder (GAD), fibromyalgia (FM) and 2 more (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve at 72 hours. Started May 2008; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)fibromyalgia (FM)neuropathic painchronic musculoskeletal pain
Beyond the preview
Go deeper on NCT02291341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291341.